SCHOTT Pharma AG & Co. KGaA specializes in drug containment solutions and delivery systems for injectable medications. The company operates through two main segments: Drug Containment Solutions (DCS), which produces vials, ampoules, and cartridges, and Drug Delivery Systems (DDS), which focuses on prefillable glass and polymer syringes. Its products are manufactured using high-performance materials like Type I borosilicate glass and medical-grade cyclic olefin copolymer to ensure drug stability and safety. Serving major pharmaceutical companies worldwide, SCHOTT Pharma provides packaging for sensitive biologics, vaccines, and small molecules. The company was established as a standalone entity following a carve-out from its parent company, SCHOTT AG, and went public in 2023.
